A 5-microRNA signature derived from core binding factor-AML is predictive in adult and childhood AML.

Autor: Gabra MM; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada., Chow JT; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada., Kim T; Department of Computer Science, University of Toronto, Toronto, Ontario, Canada., Son MH; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Arruda A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Woolley JF; Department of Pharmacology & Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK., Zhang Z; Department of Computer Science, University of Toronto, Toronto, Ontario, Canada; The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Minden MD; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada., Salmena L; Department of Pharmacology & Toxicology, University of Toronto, Toronto, Ontario, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Electronic address: leonardo.salmena@utoronto.ca.
Jazyk: angličtina
Zdroj: Leukemia research [Leuk Res] 2022 Dec; Vol. 123, pp. 106968. Date of Electronic Publication: 2022 Oct 08.
DOI: 10.1016/j.leukres.2022.106968
Abstrakt: Competing Interests: Conflict of Interests All authors declare no conflicts of interest.
Databáze: MEDLINE
Externí odkaz: